CNS
Overvalued by 49.8% based on the discounted cash flow analysis.
Market cap | $3.77 Billion |
---|---|
Enterprise Value | $3.81 Billion |
Dividend Yield | $2.45 (3.32%) |
Earnings per Share | $3 |
Beta | 1.35 |
Outstanding Shares | 51,165,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 23.31 |
---|---|
PEG | 145.85 |
Price to Sales | 6.61 |
Price to Book Ratio | 7.27 |
Enterprise Value to Revenue | 6.66 |
Enterprise Value to EBIT | 17.67 |
Enterprise Value to Net Income | 23 |
Total Debt to Enterprise | 0.04 |
Debt to Equity | 0.27 |
No data
No data